Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease

Written By Yiran Gan
Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease - Yang et al. 2017

Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease

Publication Date: 2017.07.27

Authors: S. Y. Yang, M. J. Chiu, T. F. Chen, and H. E. Horng

Journal: Neurology and Therapy 6: S37-S56 (2017)

Citation

S. Y. Yang, M. J. Chiu, T. F. Chen, and H. E. Horng, "Detection of plasma biomarkers using immunomagnetic reduction: A promising method for the early diagnosis of Alzheimer's disease", Neurology and Therapy 6: S37-S56 (2017).

Article Link

https://link.springer.com/article/10.1007/s40120-017-0075-7

© 2017 Yang, Chiu, Chen, and Horng

Neurology and Therapy | Volume 6, Pages S37-S56

Yiran Gan
Previous

A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome
Next

Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies